Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma

2013-02-01

International Journal of Cancer , Volume 132 - Issue 3 p. E106- E115

Additional Metadata
THEME	Life Sciences (theme 5)
Publisher	Wiley
Journal	International Journal of Cancer
Grant	This work was funded by the The Netherlands Organisation for Scientific Research (NWO); grant id nwo/639.072.309 - Statistical Models for Structural Genetic Variants in the Genome of the Netherlands
Organisation	Evolutionary Intelligence
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schramm, A., Köster, J., Marschall, T., Martin, M., Heilmann, M., Fielitz, K., Büchel, G., Barann, M., Esser, D., Rosenstiel, P., Rahmann, S., Eggert, A.& Schulte, J. (2013). Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma. International Journal of Cancer, 132(3), E106–E115.

Additional Files
Fulltext Final Version
Publisher Version

Publication